ES2461591T3 - Expresión de proteínas en células de roedor - Google Patents

Expresión de proteínas en células de roedor Download PDF

Info

Publication number
ES2461591T3
ES2461591T3 ES06806552.3T ES06806552T ES2461591T3 ES 2461591 T3 ES2461591 T3 ES 2461591T3 ES 06806552 T ES06806552 T ES 06806552T ES 2461591 T3 ES2461591 T3 ES 2461591T3
Authority
ES
Spain
Prior art keywords
ebna
expression
protein
cho cell
ebv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06806552.3T
Other languages
English (en)
Spanish (es)
Inventor
Ulrich Goepfert
Erhard Kopetzki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2461591T3 publication Critical patent/ES2461591T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16251—Methods of production or purification of viral material
    • C12N2710/16252—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES06806552.3T 2005-10-28 2006-10-26 Expresión de proteínas en células de roedor Active ES2461591T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05023611 2005-10-28
EP05023611 2005-10-28
PCT/EP2006/010308 WO2007048601A1 (en) 2005-10-28 2006-10-26 Protein expression in rodent cells

Publications (1)

Publication Number Publication Date
ES2461591T3 true ES2461591T3 (es) 2014-05-20

Family

ID=36061413

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06806552.3T Active ES2461591T3 (es) 2005-10-28 2006-10-26 Expresión de proteínas en células de roedor

Country Status (7)

Country Link
US (1) US7892790B2 (https=)
EP (1) EP1945781B1 (https=)
JP (2) JP5666776B2 (https=)
CN (1) CN101341252B (https=)
CA (1) CA2624685C (https=)
ES (1) ES2461591T3 (https=)
WO (1) WO2007048601A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530233B2 (en) * 2007-10-02 2013-09-10 Genetai Inc Expression vector with enhanced gene expression capacity and method for using the same
CA2722835C (en) 2008-05-15 2018-11-27 National Research Council Of Canada Process, vectors and engineered cell lines for enhanced large-scale transfection
US8822214B2 (en) * 2009-09-15 2014-09-02 Medimmune Limited Cells for transient expression and uses thereof
CN102453729B (zh) * 2010-10-29 2016-03-02 宁波安柯生物技术有限公司 一种快速高通量生产重组蛋白的平台
WO2017032834A1 (en) * 2015-08-25 2017-03-02 Lonza Biologics Plc. Mammalian expression system
US10464840B2 (en) * 2016-10-05 2019-11-05 Corning Incorporated Near infrared shielding and laser-resistant window
CN114174540A (zh) * 2019-07-25 2022-03-11 豪夫迈·罗氏有限公司 用于检测爱泼斯坦巴尔病毒(ebv)的组合物和方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686186A (en) 1984-09-26 1987-08-11 Wisconsin Alumni Research Foundation Recombinant vector and eukaryotic host transformed thereby
IE913929A1 (en) 1990-11-13 1992-05-20 Immunex Corp Bifunctional selectable fusion genes
AU6953394A (en) 1993-05-21 1994-12-20 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
EP0760861A1 (en) 1994-05-20 1997-03-12 The Board Of Trustees Of The Leland Stanford Junior University An autonomous replication system for mammalian cells
US6479279B2 (en) 1995-12-29 2002-11-12 Estonian Biocentre Episomal vectors and uses thereof
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
US5976807A (en) 1998-03-18 1999-11-02 Pharmacopeia, Inc. Eukaryotic cells stably expressing genes from multiple transfected episomes
MY139948A (en) 2000-09-28 2009-11-30 Bayer Corp Enhanced transfection system
AU2002257440A1 (en) 2001-05-07 2002-11-18 National Research Council Of Canada Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
WO2004018506A2 (en) 2002-08-22 2004-03-04 Cytos Biotechnology Ag Inducible alphaviral/orip based gene expression system
AU2003283174A1 (en) 2002-12-11 2004-06-30 Cytos Biotechnology Ag Method for protein production
AR046071A1 (es) 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
US7919270B2 (en) * 2003-09-09 2011-04-05 Acyte Biotech Pty Ltd Mammalian expression system

Also Published As

Publication number Publication date
WO2007048601A1 (en) 2007-05-03
EP1945781B1 (en) 2014-03-05
US7892790B2 (en) 2011-02-22
CN101341252B (zh) 2011-08-17
US20100021965A1 (en) 2010-01-28
JP5666776B2 (ja) 2015-02-12
CA2624685A1 (en) 2007-05-03
JP2009513117A (ja) 2009-04-02
CN101341252A (zh) 2009-01-07
CA2624685C (en) 2014-06-03
EP1945781A1 (en) 2008-07-23
JP2012090633A (ja) 2012-05-17

Similar Documents

Publication Publication Date Title
EP2164972B1 (en) Promoter
ES2413379T3 (es) Presentación en la superficie celular de isoformas polipeptídicas mediante ultralectura de codón de terminación
ES2230908T3 (es) Procedimiento para la preparacion de celulas recombinantes.
TWI507526B (zh) 包含嵌合巨細胞病毒啓動子及加強子序列的表現載體
JP2012090633A (ja) 齧歯動物細胞におけるタンパク質発現
CA2654415A1 (en) Protein production using eukaryotic cell lines
ES2699718T3 (es) Células para expresión transitoria y usos de las mismas
US11591383B2 (en) Method for selecting polypeptide producing cells
JP7264353B2 (ja) 新規ベクターおよびその利用
HK40046638A (en) Novel vector and use thereof
HK40008758A (en) Improved method for selecting polypeptide producing cells
HK40008758B (en) Improved method for selecting polypeptide producing cells
HK1232253B (zh) 生产多肽的方法
BRPI0813963B1 (pt) ÁCIDO NUCLEICO, PLASMÍDEO, E MÉTODOS PARA A PRODUÇÃO E PARA MELHORAR A EXPRESSÃO DE UMA IMUNOGLOBULINA DA CLASSE IgG EM UMA CÉLULA DE MAMÍFERO